Table 3. Summary of the optimised protocols proposed by the model.
Etoposide |
Cisplatin |
|||
---|---|---|---|---|
Protocol | Time | Dose | Time | Dose |
OP1 | 0–1 h | 80 mg m−2 | 1–2 h | 80 mg m−2 |
12–84 h | 160 mg m−2 | |||
OP2 (intensified) | 0–1 h | 80 mg m−2 | 1–2 h | 80 mg m−2 |
12–108 h | 300 mg m−2 | |||
OP3 (14-day cycle) | 0–1 h | 40 mg m−2 | 1–2 h | 50 mg m−2 |
6–78 h | 105 mg m−2 |